The 7 analysts offering 12-month price forecasts for Rigel Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 15.00 and a low estimate of 0.90. The median estimate represents a +15.27% increase from the last price of 1.74.
The current consensus among 7 polled investment analysts is to Hold stock in Rigel Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.09
Reporting Date Mar 02
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.